about
Technical challenges in the isolation and analysis of circulating tumor cellsStereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell CarcinomaBest of the 2015 AUA Annual Meeting: Highlights From the 2015 American Urological Association Annual Meeting, May 15-19, 2015, New Orleans, LACorrelation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer.A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)PSMA-Targeted 18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy.Nucleolin Staining May Aid in the Identification of Circulating Prostate Cancer Cells.Increased intra-abdominal fat predicts perioperative complications following minimally invasive partial nephrectomy.The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer.Pathological characteristics and radiographic correlates of complex renal cystsPerioperative outcomes of robotic partial nephrectomy for intrarenal tumorsSalvage robot-assisted partial nephrectomy for the management of renal cell carcinoma following failed stereotactic radiotherapyPartial nephrectomy for the treatment of translocation renal cell carcinoma.PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?Medical student attitudes before and after participation in rural health fairs.Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor.Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters.Extent of renal vein invasion influences prognosis in patients with renal cell carcinoma.Computed Tomography Appearance of Renal Hybrid Oncocytic/Chromophobe TumorsProtein kinase C epsilon: an oncogene and emerging tumor biomarker.Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy.Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer.Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.Mortality trends and the impact of lymphadenectomy on survival for renal cell carcinoma patients with distant metastasis.Pharmacotherapy of head and neck squamous cell carcinoma.Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells.A simple selection-free method for detecting disseminated tumor cells (DTCs) in murine bone marrow.Surgical resection of a virilizing adrenal mass with extensive tumor thrombus.Evaluation and management of small renal masses: looking beyond the tumor margin.Preoperative patient counseling for diagnostic renal biopsy and complications with renal radiofrequency ablation.Bland thrombus association with tumour thrombus in renal cell carcinoma: analysis of surgical significance and role of inferior vena caval interruption.Diagnosis and treatment of bladder cancer: how can we improve?Transplantation techniques for the resection of renal cell carcinoma with tumor thrombus: a technical description and review.Development of a surgical safety checklist for the performance of radical nephrectomy and tumor thrombectomy.Inferior vena cava resection and reconstruction: technical considerations in the surgical management of renal cell carcinoma with tumor thrombus.Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind).Reducing morbidity of pelvic and retroperitoneal lymphadenectomy.Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database.Grade heterogeneity in small renal masses: potential implications for renal mass biopsy.The financial impact of robotic technology for partial and radical nephrectomy.
P50
Q26741646-46F75ABA-F5A3-4152-9330-8C06037DBF22Q26774094-31DA05C3-3111-4E5F-B2EA-F3CCB5B24E6EQ26778881-82F56FE8-3E76-4368-9124-CE9A9F935B9CQ31137270-D1F3266E-602D-4683-B2B4-9908D6C7783AQ32173730-37D4F554-4A3F-4659-AF4B-537F7EED8C91Q33917916-E1D5DD09-BD9C-47A6-9270-C15F87999E98Q34047941-3E2ABC28-BDBC-4FC5-B95B-0F904E8B6CABQ34642342-60C0675B-DA5F-44DD-B76A-5D9F95D6626BQ35095959-A618F520-2D4D-4899-8EAB-501F74F9913AQ35111920-7A680846-6C09-4035-B3C3-73B7DEDDDE76Q35156668-1C26FFA2-647B-43AE-AED9-64B737AD3B11Q36124478-1035AC02-E046-4030-8A93-A29D5114DA46Q36288139-37CC7394-ECEF-4E35-A42E-6413C0B70A3EQ36421964-B6D42ED2-68FE-47A7-8200-DA6B1EBA8494Q36479967-8C30CEF0-166E-402A-921C-087000179679Q36545270-A0A64C75-FC9E-4F18-B104-4727F08B9CE3Q36607592-421635E9-83EA-4483-A087-B089C6570B23Q36788797-9DE82EB5-00F4-420C-960E-36E8CCE80C5AQ37104297-4B2ECC38-D98B-407E-AABA-3F7AB53AD131Q37109953-32B4D940-50AF-443D-B099-4E766337C450Q37146163-99A8C85B-9D50-47BB-9520-F2CDA6262AD0Q37375154-D351653A-599A-4C73-B749-E85C476A92B0Q37390674-E5D93370-8FA8-4980-8E60-62E07C9EF50BQ37515882-DF3504AD-1990-4073-BD5B-73A3B7F3F8DBQ37575538-15DE630B-8C20-45AE-BC92-3D8BDCB36191Q37595721-C10E385C-DDEB-4703-B35C-D67F740DA7E4Q37688444-847C2E2A-E235-4740-A5CD-5C0CDD6C5C79Q37894138-58CF3451-C151-4DFA-B1BA-4A32FF6E4FE0Q37967420-12510A80-4EEF-46CF-A0FB-9AE0231ADDCBQ37976280-A9E8D8C6-1DA3-46B2-BE1F-E5F3854A2FF2Q38006058-4DF617E6-5E85-407F-BD1B-E83D5E574291Q38018207-6EA5F1FF-0CCD-4388-9D63-7B7EAACD18A2Q38043212-E4B2E81D-CE61-45B2-BE72-4D9DB9409802Q38067518-DE9FD8F8-AD82-437A-BCE9-658B14C1CB23Q38090194-712677EE-2560-43A9-B38A-7F7AA952875CQ38114229-3B0168C3-AD22-434C-87B5-50C1A7246095Q38114365-0C97F915-A9F2-44FE-85AA-9E212E762A08Q38188120-803E8B93-70DF-4D7F-91A4-86FBF722A2A3Q38222827-D1E7D651-5CA7-4E6E-9F55-5A251AC72776Q38244222-10E50799-B402-401E-BADE-54379B995FF4
P50
name
Michael A Gorin
@ast
Michael A Gorin
@en
Michael A Gorin
@es
Michael A Gorin
@nl
type
label
Michael A Gorin
@ast
Michael A Gorin
@en
Michael A Gorin
@es
Michael A Gorin
@nl
prefLabel
Michael A Gorin
@ast
Michael A Gorin
@en
Michael A Gorin
@es
Michael A Gorin
@nl